Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-24 @ 5:40 PM
Study NCT ID:
NCT02726568
Status:
UNKNOWN
Last Update Posted:
2019-02-19
First Post:
2016-03-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2021-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12
Completion Date Type:
ESTIMATED
First Submit Date:
2016-03-29
First Submit QC Date:
None
Study First Post Date:
2016-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-15
Last Update Post Date:
2019-02-19
Last Update Post Date Type:
ACTUAL